Equities

Manuka Inc

MNKA:PKL

Manuka Inc

Actions
  • Price (USD)0.013
  • Today's Change0.00 / 0.00%
  • Shares traded1.00
  • 1 Year change-89.17%
  • Beta-1.5722
Data delayed at least 15 minutes, as of Jul 05 2024 14:30 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Manuka, Inc., formerly Artemis Therapeutics, Inc., is focused on offering facial skincare products based on Manuka honey and bee venom. The Company’s products include Face Serum with Manuka Honey and Bee Venom, Face Serum with Enhanced Vitamin C, Day Cream, Nourishing Night Cream with Manuka Honey and Nee Venom, Eye Cream with Manuka Honey and Bee Venom, Face Cleanser Gel and Face Serum. Its Face Serum with Manuka Honey and Bee Venom supports blurring and reduces skin wrinkles. It regenerates skin cells and gives a young and vital appearance to the skin. The bee venom encourages natural skin revival, boosts production of Collagen, enhances skin elasticity and has healing properties for damages skin cells.

  • Revenue in USD (TTM)671.00k
  • Net income in USD-1.14m
  • Incorporated2003
  • Employees4.00
  • Location
    Manuka Inc3 Eliezer Vardinon St.PETAH TIKVA 4959507IsraelISR
  • Phone+1 6 462331454
  • Fax+1 3 026555049
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Herborium Group, Inc.340.33k-318.65k1.09m2.00------3.21-0.3492-0.34920.3672-1.162.323.8925.94---216.97-490.56----58.3156.36-93.63-186.810.0331-39.14----19.45-18.15120.44------
LadRx Corp0.001.66m1.11m2.000.65043.210.663--3.443.440.000.69730.00----0.0096.28-58.97---78.44------------0.00------106.96------
Actavia Life Sciences Inc0.00-406.65k1.23m1.00---------0.0005-0.00050.00-0.00280.00----0.00-805.97-158.17---------------5.63---------547.04------
Dermata Therapeutics Inc0.00-8.69m1.33m8.00--4.13-----24.67-24.670.000.57170.00----0.00-120.05---146.08--------------0.00------18.90------
Salarius Pharmaceuticals Inc0.00-8.92m1.36m2.00--0.3362-----21.71-21.710.006.770.00----0.00-119.38-69.27-193.68-79.89-------675.70----0.031------60.32------
Manuka Inc671.00k-1.14m1.46m4.00------2.17-0.0128-0.01280.0066-0.01242.410.941237.28167,750.00-410.43-463.75----88.08---170.04-732.150.0194-----------854.23------
180 Life Sciences Corp0.00-16.24m1.47m4.00---------41.54-41.540.00-1.120.00----0.00-176.90-42.39-354.57-56.41-----------385.88--------48.52------
Drazcanna Inc2.05m-5.71m1.47m--------0.7192-0.7024-0.70240.24920.10040.685--23.88---191.19---643.20---11.20---279.10-----33.040.2445--------------
Virpax Pharmaceuticals Inc0.00-16.89m1.58m7.00---------14.42-14.420.00-1.040.00----0.00-156.21-87.52-241.52-116.56--------------------29.84------
Seelos Therapeutics Inc1.97m-27.12m1.59m10.00------0.804-44.59-44.592.16-17.360.1449--2.24131,600.00-198.99-180.05---386.76-----1,373.61-9,612.88------------48.48------
CNS Pharmaceuticals Inc0.00-17.46m1.76m3.00---------179.17-179.170.00-20.760.00----0.00-384.86-132.47---185.75---------------------23.42------
Hi-Great Group Holding Co101.27k-113.56k1.78m--------17.58-0.0011-0.00110.001-0.00110.78870.8027-----88.44------48.60---112.14--0.0197-48.81-----47.32---3,789.70------
Panbela Therapeutics Inc0.00-27.26m1.78m7.00---------20.38-20.380.00-0.65630.00----0.00-201.94-215.89-809.38-476.38-----------161.794.16------27.68------
Data as of Jul 05 2024. Currency figures normalised to Manuka Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.